Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
carboplatin
i
Other names:
CBDCA, JM-8, JM8, NSC-241240, NSC-241240, NSC 241240, NSC-241-240
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(208)
News
Trials
Company:
Generic mfg.
Drug class:
Tubulin polymerization promoter
Related drugs:
‹
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
ModraDoc006/r (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
paclitaxel (178)
docetaxel (163)
TH 1902 (8)
docetaxel nanoformulation (0)
docetaxel polymeric micelle (0)
CPO100 (0)
LE-DT (0)
ModraDoc006/r (0)
STK-01 (0)
BAY86-5302 (0)
UTD1 (0)
›
Associations
(208)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
carboplatin + micellar paclitaxel
Sensitive: A1 - Approval
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
carboplatin + albumin-bound paclitaxel
Sensitive: A1 - Approval
carboplatin + albumin-bound paclitaxel
Sensitive
:
A1
carboplatin + albumin-bound paclitaxel
Sensitive: A1 - Approval
carboplatin + albumin-bound paclitaxel
Sensitive
:
A1
No biomarker
Oral Cancer
No biomarker
Oral Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Oral Cancer
No biomarker
Oral Cancer
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Oropharyngeal Cancer
No biomarker
Oropharyngeal Cancer
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
carboplatin + 5-fluorouracil
Sensitive: A2 - Guideline
carboplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Malignant Pleural Mesothelioma
No biomarker
Malignant Pleural Mesothelioma
carboplatin + pemetrexed
Sensitive: A2 - Guideline
carboplatin + pemetrexed
Sensitive
:
A2
carboplatin + pemetrexed
Sensitive: A2 - Guideline
carboplatin + pemetrexed
Sensitive
:
A2
No biomarker
Nasopharyngeal Carcinoma
No biomarker
Nasopharyngeal Carcinoma
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + albumin-bound paclitaxel
Sensitive: A2 - Guideline
carboplatin + albumin-bound paclitaxel
Sensitive
:
A2
carboplatin + albumin-bound paclitaxel
Sensitive: A2 - Guideline
carboplatin + albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + gemcitabine
Sensitive: A2 - Guideline
carboplatin + gemcitabine
Sensitive
:
A2
carboplatin + gemcitabine
Sensitive: A2 - Guideline
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + ifosfamide
Sensitive: A2 - Guideline
carboplatin + ifosfamide
Sensitive
:
A2
carboplatin + ifosfamide
Sensitive: A2 - Guideline
carboplatin + ifosfamide
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
carboplatin + pegylated liposomal doxorubicin
Sensitive
:
A2
carboplatin + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
carboplatin + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Peritoneal Cancer
No biomarker
Peritoneal Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + gemcitabine
Sensitive: A2 - Guideline
carboplatin + gemcitabine
Sensitive
:
A2
carboplatin + gemcitabine
Sensitive: A2 - Guideline
carboplatin + gemcitabine
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + ifosfamide
Sensitive: A2 - Guideline
carboplatin + ifosfamide
Sensitive
:
A2
carboplatin + ifosfamide
Sensitive: A2 - Guideline
carboplatin + ifosfamide
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
carboplatin + pegylated liposomal doxorubicin
Sensitive
:
A2
carboplatin + pegylated liposomal doxorubicin
Sensitive: A2 - Guideline
carboplatin + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
No biomarker
Fallopian Tube Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Penile Cancer
No biomarker
Penile Cancer
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
carboplatin + paclitaxel
Sensitive: A2 - Guideline
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Testicular Seminoma
No biomarker
Testicular Seminoma
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Non Small Cell Lung Cancer
No biomarker
Non Small Cell Lung Cancer
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Malignant Pleural Mesothelioma
No biomarker
Malignant Pleural Mesothelioma
carboplatin + raltitrexed
Sensitive: A2 - Guideline
carboplatin + raltitrexed
Sensitive
:
A2
carboplatin + raltitrexed
Sensitive: A2 - Guideline
carboplatin + raltitrexed
Sensitive
:
A2
No biomarker
Thymic Carcinoma
No biomarker
Thymic Carcinoma
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Thymoma
No biomarker
Thymoma
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
carboplatin
Sensitive: A2 - Guideline
carboplatin
Sensitive
:
A2
No biomarker
Ovarian Cancer
No biomarker
Ovarian Cancer
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
carboplatin + docetaxel
Sensitive: A2 - Guideline
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
carboplatin + etoposide IV
Sensitive: A2 - Guideline
carboplatin + etoposide IV
Sensitive
:
A2
carboplatin + etoposide IV
Sensitive: A2 - Guideline
carboplatin + etoposide IV
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login